Follow-up of patients with progressive multiple sclerosis treated with autologous Epstein¿Barr virus-specific T cell therapy (2018–2019)

Grant type:
Multiple Sclerosis Society of Queensland
Researchers:
Funded by:
Multiple Sclerosis Society of Queensland